Clinical Trials in Atlanta

Showing 19061-19080 of 19,805 trials

Safety Study of XL999 in Adults With Non-Small-Cell Lung Cancer

NCT00491699

The purpose of this study is to determine the safest dose of XL999 and how well subjects with Non-Small-Cell Lung Cancer tolerate XL999. XL999 is a small molecule inhibitor of multiple kinases including VEGFR, PDGFR, FGFR, FLT-3, and Src, which are involved in tumor cell growth, formation of new blood vessels (angiogenesis), and metastasis.

Non-Small-Cell Lung Cancer

Symphony Evolution, Inc.2 participantsStarted Aug 2007

Los Angeles, California, United States • Atlanta, Georgia, United States • Detroit, Michigan, United States +2 more locations

TERMINATEDPhase 4< 1 mile

Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)

NCT00620074

This study will test the effectiveness and the safety of giving two antifungal agents (voriconazole and anidulafungin) together to treat invasive aspergillosis in patients who are unable to tolerate polyene therapy.

Aspergillosis

Pfizer6 participantsStarted Aug 2008

Atlanta, Georgia, United States • Detroit, Michigan, United States • Fort Worth, Texas, United States +1 more locations

Safety Study of XL999 in Adults With Non-Small-Cell Lung Cancer

Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)

Find Trials by Condition in Atlanta

A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen

Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed

Normal Pressure Hydrocephalus (NPH) Registry

Pilot Study of the Efficacy and Safety of Lidoderm Patch in the Treatment of Low Back Pain

Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis

Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary Hypogonadism

Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass

PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease

Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/Ritonavir

A Study of a Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon

Randomized Study of Human-Milk Based Nutrition Versus Formula in Premature Infants

Study of Immediate Post-Operative Intravesical Instillation of Chemophase® in Patients With Superficial Bladder Cancer

Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia

Study of XL999 in Patients With Previously Treated Ovarian Cancer

Bryostatin 1 and High Dose Cytarabine in Treating Patients With Refractory or Relapsed Leukemia or Lymphoma

Study of XL999 in Adults With Solid Tumors

Study Of SU011248 In Combination With Paclitaxel/Carboplatin In Patients With Advanced Solid Tumors

Detection of Amplification of Her2 Fluorescent in Situ Hybridization (FISH) in Breast Tissue Sections